Ann D. Thor
Impact in
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 0.1%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
Papers in
- Oncology 94
- HER2/EGFR in Cancer Research 45
- Cancer-related Molecular Pathways 26
-
- Glycosylation and Glycoproteins Research 19
- Metabolism, Diabetes, and Cancer 16
- PI3K/AKT/mTOR signaling in cancer 11
- Co-authors
- Susan M. Edgerton (55 shared papers)Jeffrey Schlom (30 shared papers)Dan H. Moore (18 shared papers)Bolin Liu (25 shared papers)S M Edgerton (14 shared papers)Helene S. Smith (5 shared papers)Daniel F. Hayes (12 shared papers)Donald A. Berry (13 shared papers)
- Journals
- Journal of Clinical Oncology (16 papers)Cancer Research (11 papers)Human Pathology (11 papers)JNCI Journal of the National Cancer Institute (8 papers)Breast Cancer Research and Treatment (8 papers)
- Partner nations
- United StatesCanadaChina
In The Last Decade
Ann D. Thor
201 papers receiving 17.8k citations
Ann D. Thor's Hit Papers
Peers
Comparison fields: 5 of 139
- Cancer Research 4.9k
- Oncology 7.8k
- Radiology, Nuclear Medicine and Imaging 2.8k
- Molecular Biology 7.3k
- Pathology and Forensic Medicine 1.7k
Countries citing papers authored by Ann D. Thor
This map shows the geographic impact of Ann D. Thor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann D. Thor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann D. Thor more than expected).
Fields of papers citing papers by Ann D. Thor
This network shows the impact of papers produced by Ann D. Thor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann D. Thor. The network helps show where Ann D. Thor may publish in the future.
Co-authors
The 25 scholars most cited alongside Ann D. Thor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 209 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Revision of the American Joint Committee on Cancer Staging System for Breast Cancer Hit paper breakdown → | 2002 | 887 |
| 2 | Prognostic Factors in Breast Cancer Hit paper breakdown → | 2000 | 842 |
| 3 | Maspin, a Serpin with Tumor-Suppressing Activity in Human Mammary Epithelial Cells Hit paper breakdown → | 1994 | 783 |
| 4 | c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer Hit paper breakdown → | 1994 | 780 |
| 5 | Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers Hit paper breakdown → | 1992 | 637 |
| 6 | 2008 | 487 | |
| 7 | 1998 | 473 | |
| 8 | 1996 | 449 | |
| 9 | 1992 | 445 | |
| 10 | 2009 | 433 | |
| 11 | 2007 | 405 | |
| 12 | Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. | 1986 | 393 |
| 13 | 2009 | 338 | |
| 14 | 2014 | 310 | |
| 15 | Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. | 2001 | 263 |
| 16 | 1993 | 255 | |
| 17 | 2003 | 246 | |
| 18 | 2006 | 212 | |
| 19 | 1994 | 209 | |
| 20 | 1986 | 205 |
About Ann D. Thor
Ann D. Thor is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Genetics, having authored 209 papers that have together received 18.4k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (45 papers), Monoclonal and Polyclonal Antibodies Research (42 papers), Cancer-related Molecular Pathways (26 papers), Glycosylation and Glycoproteins Research (19 papers), Breast Cancer Treatment Studies (17 papers), Metabolism, Diabetes, and Cancer (16 papers), Radiopharmaceutical Chemistry and Applications (16 papers) and PI3K/AKT/mTOR signaling in cancer (11 papers). The work is most often cited by research in Cancer Research (4.9k citations), Oncology (7.8k citations), Radiology, Nuclear Medicine and Imaging (2.8k citations), Molecular Biology (7.3k citations) and Pathology and Forensic Medicine (1.7k citations). Ann D. Thor has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Susan M. Edgerton, Jeffrey Schlom, Dan H. Moore, Bolin Liu, S M Edgerton, Helene S. Smith, Daniel F. Hayes, Donald A. Berry, Zeying Fan and Cheryl A. Szpak. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Human Pathology, JNCI Journal of the National Cancer Institute and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.